Patents by Inventor Igor Bilinsky

Igor Bilinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9034323
    Abstract: Provided are methods for control of post-prandial glucose in diabetic subjects by administering a fast-acting insulin analog and a hyaluronidase degrading enzyme. The fast-acting insulin analog and a hyaluronidase are administered between 15 minutes before the meal and 30 minutes after commencing the meal.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: May 19, 2015
    Assignee: Halozyme, Inc.
    Inventors: Gregory I. Frost, Igor Bilinsky, Daniel Vaughn, Barry Sugarman
  • Publication number: 20140135682
    Abstract: Provided are methods for control of post-prandial glucose in diabetic subjects by administering a fast-acting insulin analog and a hyaluronidase degrading enzyme. The fast-acting insulin analog and a hyaluronidase are administered between 15 minutes before the meal and 30 minutes after commencing the meal.
    Type: Application
    Filed: September 24, 2013
    Publication date: May 15, 2014
    Inventors: Gregory I. Frost, Igor Bilinsky, Daniel Vaughn, Barry Sugarman
  • Patent number: 8568713
    Abstract: Provided are methods for control of post-prandial glucose in diabetic subjects by administering a fast-acting insulin analog and a hyaluronidase degrading enzyme. The fast-acting insulin analog and a hyaluronidase are administered between 15 minutes before the meal and 30 minutes after commencing the meal.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: October 29, 2013
    Assignee: Halozyme, Inc.
    Inventors: Gregory I. Frost, Igor Bilinsky, Daniel Vaughn, Barry Sugarman
  • Patent number: 8318154
    Abstract: Provided are combinations, compositions and kits containing an fast-acting insulin composition and a hyaluronan degrading enzyme composition formulated for parenteral administration. Such products can be used in methods of treating insulin-treatable diseases or conditions. Also provided are methods for administration of a fast-acting insulin and a hyaluronan degrading enzyme.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: November 27, 2012
    Assignee: Halozyme, Inc.
    Inventors: Gregory I. Frost, Igor Bilinsky, Daniel Vaughn, Barry Sugarman
  • Publication number: 20120251517
    Abstract: Provided are methods for control of post-prandial glucose in diabetic subjects by administering a fast-acting insulin analog and a hyaluronidase degrading enzyme. The fast-acting insulin analog and a hyaluronidase are administered between 15 minutes before the meal and 30 minutes after commencing the meal.
    Type: Application
    Filed: May 18, 2012
    Publication date: October 4, 2012
    Inventors: Gregory I. Frost, Igor Bilinsky, Daniel Vaughn, Barry Sugarman
  • Publication number: 20090304665
    Abstract: Provided are combinations, compositions and kits containing an fast-acting insulin composition and a hyaluronan degrading enzyme composition formulated for parenteral administration. Such products can be used in methods of treating insulin-treatable diseases or conditions. Also provided are methods for administration of a fast-acting insulin and a hyaluronan degrading enzyme.
    Type: Application
    Filed: April 28, 2009
    Publication date: December 10, 2009
    Inventors: Gregory I. Frost, Igor Bilinsky, Daniel Vaughn, Barry Sugarman